Saratov JOURNAL of Medical and Scientific Research

Rituximab treatment efficacy in a patient with systemic lupus erythematosus with severe thrombocytopenia

Year: 2018, volume 14 Issue: №3 Pages: 417-419
Heading: rheumatology Article type: Case report
Authors: Alexandrova O.L., Nikitina N.M., Magdeeva N.A., Shmelkova M.Yu., Grigoryeva S.N.
Organization: Saratov Regional Clinical Hospital, Saratov State Medical University
Summary:

The article presents a clinical case of systemic lupus erythematosus with severe thrombocytopenia in a 55 year old patient. The standard therapy of usage of high doses of glucocorticoids, cyclophosphamide and intravenous im-munoglobulin was not effective. Application of Rituximab improved the course of disease, decreased the severity of thrombocytopenia, led to disappearance of leucopenia and anemia.

Bibliography:
1. Heinlen LD, McClain MT, Merrill J, et al. Clinical criteria for systemic lupus erythematosus precede diagnosis and associated autoantibodies are present before clinical symptoms. Arthritis Rheum 2007; 56 (7): 2344-51
2. Doha A, laccarino L, Ghirardello A, et al. Long-term prognosis and causes of death in systemic lupus erythematosus. Am J Med 2006; 119 (8): 700-6
3. Nasonov EL, Aleksandrova EN, NovikovAA. Autoimmune Rheumatic Diseases — Problems of Immunopathology and Personalized Treatment. Annals of the Russian Academy of Medical Sciences 2015; 2: 169-82
4. Stasi R. How to approach thrombocytopenia. Hematology Am Soc Hematol Educ Program 2012: 191-7
5. Melikyan AL, Pustovaya El, Kalinina MV, et al. Diagnostic approach for thrombocytopenia. Hematology and Transfusiology 2016; 61 (1 Suppl 1): 23
6. Melikyan AL, Pustovaya El, Egorova EK, et al. Differential diagnosis of thrombocytopenies. Oncohematology 2017; 12 (1): 78-87
7. Cines DB, Bussel JB, Liebman HA, et al. The ITP syndrome: pathogenic and clinical diversity. Blood 2009; 11 (26): 6511-21
8. Soloviev SK, Aseeva EA, Torgashina AV. Intensive therapy of autoimmune rheumatic diseases. RMJ 2010; 11 (375); 18: 748-51
9. Chambers SA, Isenberg DA. Anti-B-cell therapy (Rituximab) in the treatment of autoimmune disease. Lupus 2005; 14(3): 210-4
10. Tsanyan ME, Soloviev SK, Torgashina AV, etal. Rituximab treatment efficacy in patient with systemic lupus erythematosus refractory to standart therapy in the long-term follow-up. Rheumatology Science and Practice 2014; 52 (2): 159-68
11. Jovancevic В, Lindholm С, Pullerits R. Anti-B-cell therapy against refractory thrombocytopenia in SLE and MCTD patients: long-term follow-up and review of the literature. Lupus 2013; 22 (7): 664-74.

AttachmentSize
2018_3_417-419.pdf268.86 KB

No votes yet